AI Insight
Research published in Nature demonstrates that the kinase WEE1 counteracts the activity of APC/C-CDH1, a protein complex that typically keeps cells in a quiescent state, thereby facilitating cell cycle re-entry and progression into S phase. Through combined experimental work and computational modeling, the study reveals a previously unrecognized role for WEE1 in promoting the transition of resting cells back into active cell division. This mechanism may explain why WEE1 inhibitors, currently used in cancer treatment, cause significant toxic side effects in normal tissues.
Why it matters
The findings provide important insights into the mechanism of action and toxicity profile of WEE1 inhibitors used in oncology. Understanding that WEE1 promotes cell cycle entry in quiescent cells could help researchers develop safer cancer therapies by predicting which normal tissues will be most affected by these drugs, potentially leading to improved dosing strategies or combination treatments that minimize harm to healthy cells.
Understand the Science
Nature, Published online: 21 October 2026; doi:10.1038/s41586-026-11188-x
Experimental and modelling data indicate that WEE1 promotes re-entry of quiescent cells into the cell cycle, potentially explaining the toxic side effects of WEE1 inhibitors in cancer therapies.
Source: WEE1 opposes APC/C<sup>CDH1</sup> activity to promote S phase entry